iifl-logo-icon 1

Aurobindo Pharma Ltd Historical Data

1,174.5
(1.13%)
Jan 14, 2025|03:31:18 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Aurobindo Pharma Ltd Historical Data

Invalid Datecalendar-icon
Invalid Datecalendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

16-DEC-2024

1,225

1,247.31,2201,244.745,0411,36,51,99,838.954,74,568

17-DEC-2024

1,244.7

1,249.11,210.651,213.7525,29662,83,10,398.92,45,324

18-DEC-2024

1,206.2

1,256.41,203.151,247.5565,3602,82,59,95,801.27,53,424

19-DEC-2024

1,241.55

1,2741,2311,254.745,9591,47,60,09,148.154,24,602

20-DEC-2024

1,254.8

1,275.31,235.71,241.746,6822,32,49,66,435.510,55,381

23-DEC-2024

1,263.65

1,2651,2381,252.9531,41598,70,08,9402,61,705

24-DEC-2024

1,258.8

1,269.11,246.31,262.4533,03971,28,96,113.552,97,679

26-DEC-2024

1,268

1,270.91,246.151,256.2518,31629,34,86,815.886,775

27-DEC-2024

1,255

1,2751,251.151,269.9531,08382,15,05,516.453,20,057

30-DEC-2024

1,273

1,307.251,265.951,298.31,18,2403,46,23,00,835.1514,66,764

31-DEC-2024

1,302

1,340.851,296.351,334.589,1913,39,13,14,210.058,64,791

01-JAN-2025

1,334.85

1,355.551,3271,353.2537,8891,27,71,93,853.94,95,990

02-JAN-2025

1,353

1,356.21,333.41,348.840,2331,54,00,44,004.356,98,097

03-JAN-2025

1,348.8

1,3501,313.651,319.4538,8031,23,35,28,197.155,08,456

06-JAN-2025

1,324

1,3251,300.11,312.831,48896,04,10,045.253,94,942

07-JAN-2025

1,314

1,3281,293.851,297.542,9221,74,43,56,857.757,78,949

08-JAN-2025

1,302.05

1,3071,262.11,281.6542,00781,21,16,192.42,35,033

09-JAN-2025

1,277.1

1,294.851,2451,248.443,3051,11,02,99,086.553,78,811

10-JAN-2025

1,248.4

1,254.71,183.051,199.5576,5992,83,20,94,456.0513,64,521

13-JAN-2025

1,191.65

1,191.651,152.451,161.470,0593,41,35,80,921.9519,35,560

Aurobindo Pharma: Related NEWS

Aurobindo Pharma Gains UK Approval for Cancer Drug Bevqolva
23 Dec 2024|11:11 PM

This is a medicine used to treat specific kinds of cancer. It can be administered only via an infusion.

Read More
Top Stocks for today - 23rd December 2024
23 Dec 2024|07:33 AM

Here are some of the stocks that may see significant price movement today: Vedanta, NHPC, Reliance Industries, etc.

Read More
Aurobindo Pharma’s Telangana unit gets 2 USFDA observations
18 Dec 2024|09:23 AM

The inspection concluded with 02 observations. The observations are procedural in nature and will be addressed within the allotted time.

Read More
Top Stocks for Today - 18th December 2024
18 Dec 2024|07:02 AM

Here are some of the stocks that may see significant price movement today: Ambuja Cements, Aurobindo Pharma, LTIMindtree, etc.

Read More
Aurobindo Pharma's Unit Eugia Pharma to Launch USFDA Approved Pazopanib in FY25
5 Dec 2024|10:34 PM

Pazopanib Tablets, 200 mg, is an alternative equivalent of Votrient Tablets, 200 mg, manufactured by Novartis and used for the treatment of specific types of cancer.

Read More
Aurobindo Pharma inks pact for respiratory products
25 Nov 2024|09:17 AM

Aurobindo Pharma stated that once commercialised, the drugs will be manufactured at Partner's facilities and marketed by both parties.

Read More
Top 10 stocks for today – 3rd October 2024
3 Oct 2024|09:07 AM

Here are some of the stocks that may see significant price movement today: Suzlon Energy, Aurobindo Pharma, Coal India, etc.

Read More
Aurobindo Pharma to pick up 49% stake in GLS Pharma
19 Sep 2024|12:32 PM

On June 17, 2022, Aurobindo purchased a 51% share in GLS Pharma from entrepreneur Suresh Pathak and his family members.

Read More
Top 10 stocks for today - 19th September, 2024
19 Sep 2024|08:52 AM

Here are some of the stocks that may see significant price movement today: IREDA, Garden Reach Shipbuilders, Nazara Tech, etc.

Read More
Aurobindo Pharma’s Subsidiary Secures USFDA Nod for Injectable Plant
18 Sep 2024|04:14 PM

The approval was based on a supplemental Abbreviated New Drug Application (sANDA) for an alternate facility for manufacturing and testing.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2024, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.